![]() Azenta Life Sciences Azenta Life Sciences (formerly known as Brooks Automation) is a provider of biological and chemical compound sample exploration and management capabilities for the life sciences industry. | |||
Founding Date | Founding Date 1978 | Founding Date 1996 | Founding Date 1984 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Burlington, US HQ Beijing, CN Guangzhou, CN Shanghai, CN Shanghai, CN Suzhou, CN Tianjin, CN see more | Locations Sunnyvale, US HQ North Ryde, AU Geel, BE São Paulo, BR Shanghai, CN København, DK Espoo, FI see more | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more |
Employees | Employees 3,5009% increase | Employees 4,7812% decrease | Employees 5,6541% decrease |
Valuation ($) | Valuation ($) 2 b | Valuation ($) N/A | Valuation ($) 9.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $593.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.1b (FY, 2025) |
Cost of goods | Cost of goods $323.5m (FY, 2025) | Cost of goods N/A | Cost of goods $577.3m (FY, 2025) |
Gross profit | Gross profit $270.3m (FY, 2025) | Gross profit N/A | Gross profit $1.5b (FY, 2025) |
Net income | Net income ($55.8m) (FY, 2025) | Net income N/A | Net income $437m (FY, 2025) |
Operating ⚠ | |||
Customers | Customers 12 k (FY, 2022) | Customers N/A | Customers 500 k (FY, 2024) |
Remaining Performance Obligations | Remaining Performance Obligations $89.8m (Q1, 2023) | Remaining Performance Obligations N/A | Remaining Performance Obligations $72m (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 98.9m | Total funding raised $ 4m |

Cepheid is a company that develops molecular diagnostic systems and tests.
View company
QIAGEN is a company that provides sample technology solutions.
View company